These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29472426)

  • 1. Uncommon cause of hypercalcaemia in metastatic breast carcinoma.
    Barnabas R; Singh A; Paul MJ; Paul TV
    BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29472426
    [No Abstract]   [Full Text] [Related]  

  • 2. Appearances of soft tissue calcification on Tc99m MDP bone scan.
    Majeed Y; Riaz S; Hassan A
    J Pak Med Assoc; 2019 Apr; 69(4):600. PubMed ID: 31000873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical scintigraphy bone scan findings with malignancy-associated extreme hypercalcemia.
    Peters N; Slattery L; Crowley C; Bennett MW; Barry J; O'Reilly S
    Breast J; 2020 Jul; 26(7):1372-1374. PubMed ID: 32212186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A 41-year-old woman with hypercalcemia and bone lesions].
    Alvarado-Cabrero I; Torres-Nuñez G; Posadas-Sibaja A; Villalón JS; Resendiz-Colosia J
    Gac Med Mex; 2003; 139(5):501-3. PubMed ID: 14635569
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypercalcaemia and metastatic bone disease: is there a causal link?
    Ralston S; Fogelman I; Gardner MD; Boyle IT
    Lancet; 1982 Oct; 2(8304):903-5. PubMed ID: 6126753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone metastases and hypercalcaemia from cutaneous squamous cell carcinoma.
    Vlachostergios PJ; Balmiki RL
    BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24913085
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypercalcaemia in an Australian hospital adult population.
    McLellan G; Baird CW; Melick R
    Med J Aust; 1968 Aug; 2(8):354-6. PubMed ID: 5686431
    [No Abstract]   [Full Text] [Related]  

  • 8. Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.
    Ralston SH; Fogelman I; Gardiner MD; Boyle IT
    Br Med J (Clin Res Ed); 1984 May; 288(6428):1405-8. PubMed ID: 6426577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of malignant hypercalcaemia in carcinoma of the breast.
    Percival RC; Yates AJ; Gray RE; Galloway J; Rogers K; Neal FE; Kanis JA
    Br Med J (Clin Res Ed); 1985 Sep; 291(6498):776-9. PubMed ID: 3929936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of hypercalcemia associated with metastases to bone from primary breast cancer.
    Ariel IM; Kempner R
    Bull Hosp Jt Dis Orthop Inst; 1988; 48(1):82-7. PubMed ID: 2840153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of the hypercalcaemia of malignancy by peritoneal dialysis.
    Miach PJ; Dawborn JK; Martin TJ; Moon WJ
    Med J Aust; 1975 Jun; 1(25):782-4. PubMed ID: 1152762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of malignant hypercalcaemia with clodronate.
    Percival RC; Paterson AD; Yates AJ; Beard DJ; Douglas DL; Neal FE; Russell RG; Kanis JA
    Br J Cancer; 1985 May; 51(5):665-9. PubMed ID: 3158326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, causes and mechanism of hypercalcaemia in a hospital population in Hong Kong.
    Shek CC; Natkunam A; Tsang V; Cockram CS; Swaminathan R
    Q J Med; 1990 Dec; 77(284):1277-85. PubMed ID: 2290921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusual case of dyspnea in metastatic breast carcinoma.
    Cronin KA; Twomey M; O'Reilly M; Carney DN
    J Pain Symptom Manage; 2011 Feb; 41(2):e1-3. PubMed ID: 21227631
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of tumour-induced hypercalcaemia in advanced breast cancer patients with three different doses of disodium pamidronate adapted to the initial level of calcaemia.
    Nesković-Konstantinović Z; Mitrović L; Petrović J; Stamatović L; Ristović Z
    Support Care Cancer; 1995 Nov; 3(6):422-4. PubMed ID: 8564348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thyrocalcitonin, betamethasone and hydration in hypercalcemia caused by bone metastases of breast carcinoma].
    Azzoini P
    Clin Ter; 1981 Apr; 97(2):147-52. PubMed ID: 7237955
    [No Abstract]   [Full Text] [Related]  

  • 17. Fatal irreversible hypercalcaemia in breast cancer.
    Cornbleet M; Bondy PK; Powles TJ
    Br Med J; 1977 Jan; 1(6054):145. PubMed ID: 832039
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bone scintigraphy in patients with malignancy associated with hypercalcemia].
    Fukunaga M; Otsuka N; Sone T; Nagai K; Ono S; Muranaka A; Furukawa T; Yanagimoto S; Tomomitsu T; Morita R
    Kaku Igaku; 1986 May; 23(5):495-8. PubMed ID: 3735789
    [No Abstract]   [Full Text] [Related]  

  • 19. Advanced cancer of the prostate combined with hypercalcaemia.
    Olsson AM; Jönsson G
    Scand J Urol Nephrol; 1977; 11(3):293-6. PubMed ID: 594676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous aminohydroxypropylidene bisphosphonate does not modify 99mTc-hydroxymethylene bisphosphonate bone scintigraphy. A prospective study.
    Macro M; Bouvard G; Le Gangneux E; Colin T; Loyau G
    Rev Rhum Engl Ed; 1995 Feb; 62(2):99-104. PubMed ID: 7600079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.